NO990322D0 - Farmas°ytisk blanding inneholdende en 5HT2c-antagonist og en D2-antagonist - Google Patents

Farmas°ytisk blanding inneholdende en 5HT2c-antagonist og en D2-antagonist

Info

Publication number
NO990322D0
NO990322D0 NO990322A NO990322A NO990322D0 NO 990322 D0 NO990322 D0 NO 990322D0 NO 990322 A NO990322 A NO 990322A NO 990322 A NO990322 A NO 990322A NO 990322 D0 NO990322 D0 NO 990322D0
Authority
NO
Norway
Prior art keywords
antagonist
mixture containing
5ht2c
pharmaceutical mixture
pharmaceutical
Prior art date
Application number
NO990322A
Other languages
English (en)
Other versions
NO990322L (no
Inventor
Thomas Paul Blackburn
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO990322D0 publication Critical patent/NO990322D0/no
Publication of NO990322L publication Critical patent/NO990322L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO990322A 1996-07-26 1999-01-25 Farmas°ytisk blanding inneholdende en 5HT2c-antagonist og en D2-antagonist NO990322L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9615767.2A GB9615767D0 (en) 1996-07-26 1996-07-26 Novel treatment
PCT/EP1997/004159 WO1998004289A2 (en) 1996-07-26 1997-07-22 Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist

Publications (2)

Publication Number Publication Date
NO990322D0 true NO990322D0 (no) 1999-01-25
NO990322L NO990322L (no) 1999-03-24

Family

ID=10797573

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990322A NO990322L (no) 1996-07-26 1999-01-25 Farmas°ytisk blanding inneholdende en 5HT2c-antagonist og en D2-antagonist

Country Status (19)

Country Link
EP (1) EP0936924A2 (no)
JP (1) JP2000516924A (no)
KR (1) KR20000029564A (no)
CN (1) CN1230894A (no)
AR (1) AR008083A1 (no)
AU (1) AU725817B2 (no)
BR (1) BR9710568A (no)
CA (1) CA2261813A1 (no)
CO (1) CO5031292A1 (no)
CZ (1) CZ23799A3 (no)
GB (1) GB9615767D0 (no)
HU (1) HUP9903619A3 (no)
IL (1) IL128219A0 (no)
NO (1) NO990322L (no)
NZ (1) NZ333813A (no)
PL (1) PL331426A1 (no)
TR (1) TR199900140T2 (no)
WO (1) WO1998004289A2 (no)
ZA (1) ZA976593B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612883D0 (en) * 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
WO2000030649A1 (en) * 1998-11-23 2000-06-02 Sepracor Inc. Pharmaceutical compositions containing olanzapine-n-oxide
US6348455B1 (en) 1998-11-23 2002-02-19 Sepracor Inc. Desmetylolanzapine compositions and methods
JP2002530339A (ja) 1998-11-23 2002-09-17 セプラコール， インク． ２−ヒドロキシメチルオランザピン組成物及び方法
AU3757500A (en) 1999-03-18 2000-10-04 Childrens Hospital Research Foundation A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications
WO2000071106A2 (en) * 1999-05-19 2000-11-30 Astrazeneca Ab Method of treating weight gain
WO2005013969A1 (en) * 2003-07-15 2005-02-17 Janssen Pharmaceutica N.V. Antipsychotic agent with socializing properties

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500998D0 (sv) * 1995-03-19 1995-03-19 Haakan Wilhelm Wikstroem New sulfone ester analogues of iso-clozapine and related structures: atypical neuroleptics

Also Published As

Publication number Publication date
ZA976593B (en) 1999-01-25
GB9615767D0 (en) 1996-09-04
AU4297297A (en) 1998-02-20
WO1998004289A3 (en) 1998-03-19
CA2261813A1 (en) 1998-02-05
BR9710568A (pt) 1999-08-17
NZ333813A (en) 2000-07-28
KR20000029564A (ko) 2000-05-25
NO990322L (no) 1999-03-24
AU725817B2 (en) 2000-10-19
IL128219A0 (en) 1999-11-30
HUP9903619A2 (hu) 2000-10-28
PL331426A1 (en) 1999-07-19
CZ23799A3 (cs) 1999-06-16
WO1998004289A2 (en) 1998-02-05
CO5031292A1 (es) 2001-04-27
AR008083A1 (es) 1999-12-09
EP0936924A2 (en) 1999-08-25
JP2000516924A (ja) 2000-12-19
HUP9903619A3 (en) 2001-03-28
CN1230894A (zh) 1999-10-06
TR199900140T2 (xx) 1999-03-22

Similar Documents

Publication Publication Date Title
NO984107L (no) Kappa-agonist-forbindelser og farmas°ytiske preparater derav
DK1275391T3 (da) Farmaceutiske sammensætninger indeholdende irbesartan og et diuretikum
NO994003L (no) Farmasoytisk blanding
NO943511L (no) Farmasöytiske preparater og anvendelse derav
DK0799577T3 (da) Peptidblanding og produkter deraf
EE04440B1 (et) Kaparetseptori opioidpeptiidid ja farmatseutilinekompositsioon
NO179474C (no) Blanding og anvendelse
NO973288D0 (no) Blanding og anvendelse
HK124397A (en) Terazosin polymorph and pharmaceutical composition
IL117349A0 (en) N-(3-benyofuranyl) urea-derivatives their preparation and pharmaceutical compositions containing them
NO965023L (no) Maltitolblanding og fremstilling derav
NO921052L (no) Geldannende blanding og anvendelse derav
NO304890B1 (no) Farmas°ytiske forbindelser og farmas°ytiske preparater
NO990322D0 (no) Farmas°ytisk blanding inneholdende en 5HT2c-antagonist og en D2-antagonist
IL118142A (en) Pharmaceutical composition containing tiagabine hydrochloride together with antioxidants and its preparation
IL126050A0 (en) Sustained-release pharmaceutical formulations containing mizolastin
HUP9602220A3 (en) Substituted 4h-piranes and pharmaceutical preparations containing them
HU9403797D0 (en) New analgesic and nootropic drugs
BR9605220A (pt) Gonadotropinas e composiçao farmacêutica
NO921666D0 (no) Farmasoeytisk blanding
SE9302429D0 (sv) New pharmaceutical preparation ii
GB9624967D0 (en) Improved analgesic drugs (6)
GB9624961D0 (en) Improved analgesic drugs(8)
GB9624968D0 (en) Improved analgesic drugs (7)
GB9624966D0 (en) Improved analgesic drugs (5)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application